CA2378396A1 — Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement
Assigned to BSP Pharma AS · Expires 2001-01-18 · 25y expired
What this patent protects
The present invention relates to a composition comprising an extract or a concentrate of Butyrospermum parkiias a dietary supplement or a pharmaceutical composition and to the use of such compositions for the preparation of a medicament or a dietary supplement for the suppression…
USPTO Abstract
The present invention relates to a composition comprising an extract or a concentrate of Butyrospermum parkiias a dietary supplement or a pharmaceutical composition and to the use of such compositions for the preparation of a medicament or a dietary supplement for the suppression of hypersensitivity and/or inflammatory reaction. The composition may optionall y be formulated with a pharmaceutically acceptable carrier for systemic or topical administration. More specifically, the invention relates to a dietar y supplement or a pharmaceutical composition comprising an extract or a concentrate of Butyrospermum parkii, wherein said extract or concentrate contains Butyrospermum-triterpenes and optionally the sterols stigmasterol, avanasterol, 24-methyl-cholest-7-enol, karitesterol A, karitesterol B and .alpha.-spinasterol.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.